Idiopathic pulmonary fibrosis trials in Denmark

In Denmark 11 Also abroad 111

11 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Phase IIb Study to Evaluate AZD8965 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
Where
Aarhus N, Copenhagen Oe, Hellerup, Odense C
Age
18 years and over
People
139 worldwide
Run by
AstraZeneca AB
See details and how to join2025-525016-41-00 · EU 2025-525016-41-00
Phase 2Taking people
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
Where
Aarhus N, Hellerup, Odense C
Age
40 years and over
People
324 worldwide
Run by
Contineum Therapeutics
See details and how to joinNCT07284459 · EU 2025-521901-42-00
Phase 2Taking people
Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease
Where
Aarhus N, Copenhagen
Age
18 years and over
People
140 worldwide
Run by
Vejle Hospital
See details and how to joinNCT06714123 · EU 2024-511131-97-00
Phase 3Not yet taking people in Denmark
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
Where
Copenhagen Oe, Hellerup, Odense C
Age
18 years and over
People
2,380 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07441408 · EU 2025-522373-10-00
Phase 2Taking people
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Where
Aarhus, Copenhagen, Hellerup, Odense C
Age
40 years and over
People
359 worldwide
Run by
AstraZeneca
See details and how to joinNCT07652658
Phase 3Taking people
Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
Where
Aarhus N, Odense C
Age
40 years and over
People
1,100 worldwide
Run by
PureTech
See details and how to joinNCT07284602 · EU 2025-524493-42-00
Phase 3Enrolling by invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
Where
Aarhus N, Hellerup, Odense C
Age
40 years and over
People
1,850 worldwide
Run by
United Therapeutics
See details and how to joinNCT04905693
Phase 3Taking people
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis
Where
Aarhus N, Hellerup, Odense C
Age
18 years and over
People
239 worldwide
Run by
Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-503697-21-01 · EU 2023-503697-21-01
Phase 3Taking people
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis
Where
Copenhagen Oe, Hellerup, Odense C
Age
18 years and over
People
249 worldwide
Run by
Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-503699-25-00 · EU 2023-503699-25-00
No phaseTaking people
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Where
Aarhus
Age
18 years to 80 years
People
500 worldwide
Run by
University of Massachusetts, Worcester
See details and how to joinNCT06855329
No phaseTaking people
Cohort of IPF Patients Experiencing an Exacerbation
Where
Hellerup
Age
18 years and over
People
50
Run by
University Hospital, Gentofte, Copenhagen
See details and how to joinNCT04442711